Huang Aiguo is more satisfied with his current life, and his work is also more satisfied, there is no heavy production task, and there is no bad living environment, what is there to be dissatisfied with? The environment in the factory has been greatly improved, and the impact of the business philosophy a while ago is really embarrassing, and now it has finally passed, but recently the boss's business philosophy and self-confidence have made Huang Aiguo feel apprehensive again, and the boss's uncle must not pounce on the moth anymore, and his brain hurts.

If there are more tea trees, they will naturally lower the price of each other, including the goods coming from outside, and naturally, the price will be lower and lower.

The old leaves of the tea tree in the health base are sold for thousands of yuan a catty, and Santang Pharmaceutical makes every effort to purchase and use it to produce tea drinks, but they do not buy outside products and tea produced in farms near the health base, which may not be anything for ordinary companies, but it is different for a listed company.

You are a listed company, how can you treat the same raw materials differently? How can there be a transfer of interests? How can you be so blatantly differentiated!

As a result, Santang Pharmaceutical was reported, and the suspected benefit transfer was sufficient.

Santang Pharmaceutical's feedback is: no, we are a listed company, only talk about quality and not quantity, the tea outside is completely different from the tea produced in our health base, we must ensure the quality rather than the lower the price, the better.

But the people who eat melons outside don't think so, there is a tenfold relationship between the price of the same variety and the same origin, how can it be possible if you are not greasy?

You say that you don't have a benefit transfer, who believes it?

So, Santang Pharmaceutical was investigated, the health base is the boss's personal, Santang Pharmaceutical is a joint-stock system, although the controlling major shareholder is this Boss Li, but after all, it is not all this boss's, so Santang Pharmaceutical was investigated as a matter of course, if there is a cat, Santang Pharmaceutical is a major shareholder who infringes on the interests of small shareholders.

In fact, this kind of thing is not uncommon, but what you do is so obviously wrong, blatant, grandiose, who do you transfer if you don't investigate? In the face of the above supervision and investigation, you always have to say something, speak with facts, Santang Pharmaceutical's response is that the standard of our procurement is different quality and different price.

Since Santang Medicine says that the quality is different, let's talk about the quality.

The tea testing data of the health base has finally come out, and the data are indeed different, such as theophylline, amino acids, trace elements selenium, etc.

When it comes to such data facts, the regulatory authorities can only give up the investigation, people's data is not the same, the quality is not the same, the price is not the same, it is a matter of course, the beneficial elements contained in it are more than ordinary tea, and the price is a lot higher than there is nothing wrong with it.

Through this incident, Santang Pharmaceutical's tea drinks and mineral water directly made a hardcore advertisement, although hardcore has been very widespread in this era, and everyone likes to use this word.

This undoubtedly made an advertisement for Santang Pharmaceutical's products, the raw materials used by people are better than others, and the price is naturally higher.

The biggest beneficiary of this turn is the tea of the health base, the sales prospect of health tea is very good, the unsalable products in the early stage are swept away, the customer believes in you again, Li Meng found that the circle he tossed has returned to the origin of selling products.

Or sell products in a down-to-earth manner, from packaging, raw materials to finished products, after-sales service to do a little perfect, the original uncle's health care project can not be said to be completely useless, floating a little high, easy to contradict.

The second is the products of Santang Medicine, mineral water and herbal tea are about to enter the peak season, but now the defects of insufficient production capacity have been exposed, the original two production lines can be supplied locally at full capacity, and now the products are selling well, and the national market must be developed, and one or two production lines can no longer meet the production demand.

"Boss, for such a situation, in addition to increasing the production line, we can also merge several FMCG beverage companies that are about to go bankrupt, and now such enterprises are not uncommon, such as Baxi, Kangli, Liyuan, etc., which were very hot sales a while ago, are large enterprises with sales of billions or tens of billions, and now due to various reasons, their sales performance has almost completely stagnated, and when they are on the verge of bankruptcy, someone will definitely make them happy. ”

Qian Cheng has been very excited recently, the drug sales data is stable, and the beverage sales performance is on fire, for him, this is the time to quickly improve the performance, such an opportunity must be seized, maybe he can prove himself in a summer, the annual salary of one million or even ten million is not unattainable, can the key boss agree?

Baxi, Kangli, Liyuan?

These companies are all big companies, and at the best time, they are all companies with a market value of tens of billions, and Santang Pharmaceutical has just reached 10 billion, and Li Meng is a little worried.

Debt management is a taboo thing for Li Meng, Li Meng doesn't like companies with assets of 10 billion and debts of 10 billion, and would rather be safer for small companies with net assets of millions and no debts, so that they can earn a few of them for themselves, and they don't have to bear high financial costs.

"Which company are you most optimistic about?"

Qian Cheng's spirit is very high, although Li Meng doesn't like to merge some such high-debt companies, but it doesn't hurt to listen to it.

Qian Cheng handed over a report to Li Meng: Liyuan Juice Analysis Report.

The scale of this company is huge, but this liability is also too scary: 23 billion. The net worth is negative 12.1 billion, losing money.

Can such a company give away for nothing? It's a burden.

Qian Cheng's brain is okay, who should give whom money to buy such a company?

Qian Cheng saw that Li Meng's face was not good-looking and immediately explained: "Boss, although this company has reached the bankruptcy standard, but once it goes bankrupt, it will be a disaster for creditors and shareholders, shareholders have lost all their money, and the machine can't get much money from selling scrap iron, and the land is also very difficult to deal with, those raw material bases are mostly contracted land, and they are losing money, and the debt committee hopes that this company will be restarted, rather than letting them die, and only a start-up capital is needed to restart this company." ”

Li Meng frowned and thought for a while and said: "Manager Qian, we have to learn to walk on two legs, one is to build two new production lines in Santang Pharmaceutical, this can be had; the other is to talk to Liyuan about the acquisition, but such a high debt is basically whoever goes in will be crushed, I mean debt-to-equity swap or discounted debt, a hard discount, otherwise I don't agree to the acquisition, even if the acquisition, in order not to affect Santang Pharmaceutical, Liyuan and Santang Medicine have to do their own thing, you can send someone to talk." ”

Li Meng's expression was ugly, like constipation, because it was beyond the reach of his mind to make Li Meng bear such a high debt.

"Okay, boss, let's talk first. ”